Increasing Cancer Incidence Accelerating Growth in Solid Tumor Treatment Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Solid Tumor Cancer Treatment Market Expected To Change From 2026 To 2030?

The solid tumor cancer treatment market has experienced a rapid increase in its size in recent years. This market is anticipated to expand from $265.41 billion in 2025 to $301.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.4%. The historical expansion is primarily due to factors such as a rise in cancer incidence, increased adoption of chemotherapy, advancements in radiation therapy, growth in oncology funding, and improvements in early diagnosis.

The solid tumor cancer treatment market size is projected to experience substantial growth in the upcoming years. It is expected to reach $501.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.6%. This anticipated growth during the forecast period stems from factors such as immunotherapy approvals, the development of targeted drug pipelines, increased adoption of personalized medicine, the expansion of oncology infrastructure, and improvements in patient survival rates. Key trends for the forecast period include the rising prominence of checkpoint inhibitors, the broadening of tumor-agnostic therapies, a greater reliance on combination regimens, the increasing influence of biomarker-driven treatments, and the expansion of outpatient oncology services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9909&type=smp

What Key Factors Are Affecting The Solid Tumor Cancer Treatment Market Demand?

The rising occurrence of cancer is a major factor driving the expansion of the solid tumor cancer treatment market in the future. This grave disease involves the rapid and uncontrolled multiplication of body cells, leading to irregular growths. Solid tumor cancer treatment involves medical procedures aimed at extracting solid tumors from individuals afflicted with cancer. For example, data from April 2024, published by the World Health Organization, an international public health body headquartered in Switzerland, indicated that in 2022, close to 20 million new instances of cancer were documented, causing roughly 10 million fatalities from the illness. Future population trends project that the yearly rate of cancer could climb to 35 million by 2050, signifying a 77% surge compared to numbers from 2022. Lung cancer stood out as the most frequently identified form, contributing approximately 2.5 million fresh diagnoses, which is equivalent to one in every eight cancers globally, making up 12.4% of all worldwide cancer cases. Consequently, the rising prevalence of cancer is fueling the expansion of the solid tumor cancer treatment market.

How Are Segments Identified Within The Solid Tumor Cancer Treatment Market Segment Framework?

The solid tumor cancer treatment market covered in this report is segmented –

1) By Type: Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures

2) By Application: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications

3) By End-Users: Hospitals, Research Institutes, Homecare

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Mitotic Inhibitors

2) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Signal Transduction Inhibitors

3) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines

4) By Hormone Therapy: Aromatase Inhibitors, Anti-Androgens, Selective Estrogen Receptor Modulators (SERMs)

5) By Surgical Procedures: Tumor Resection, Laparoscopic Surgery, Robotic-Assisted Surgery

What Trends Are Influencing Changes In The Solid Tumor Cancer Treatment Market?

Leading entities within the solid tumor cancer treatment market are concentrating on the development of sophisticated immunotherapies, targeted treatments, and cell-based interventions to elevate patient results and broaden therapeutic alternatives. For example, in July 2025, Dispatch Bio, a US-based biotechnology firm, began its operations with the objective of creating universal therapies for solid tumors. The company’s goal is to advance innovative therapeutic strategies that address a wide array of solid tumor types, enhance effectiveness across various patient groups, and expedite the creation of scalable cancer immunotherapies, which could potentially transform current standard-of-care treatments and improve long-term survival rates.

Who Are The Companies Competing Within The Solid Tumor Cancer Treatment Market?

Major companies operating in the solid tumor cancer treatment market are AstraZeneca plc, Amgen Inc., Bristol Myers Squibb & Company, Eli Lilly & Company, F Hoffmann La Roche Ltd, Merck & Co Inc, Novartis AG, Pfizer Inc, Olympus Medical Systems, Astellas Pharma Inc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd, Celldex Therapeutics Inc, AbbVie Inc, Bayer AG, Eisai Co Ltd, Exelixis Inc, Genentech Inc, Gilead Sciences Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Karyopharm Therapeutics Inc, Kyowa Kirin Co Ltd, MorphoSys AG, Regeneron Pharmaceuticals Inc, Sanofi SA, Seattle Genetics Inc, Spectrum Pharmaceuticals Inc, Taiho Pharmaceutical Co Ltd, Verastem Inc, Zymeworks Inc

Get The Full Solid Tumor Cancer Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

Which Region Is The Largest In The Solid Tumor Cancer Treatment Market?

North America was the largest region in the solid tumor cancer treatment market in 2025. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Solid Tumor Cancer Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

Browse Through More Reports Similar to the Global Solid Tumor Cancer Treatment Market 2026, By The Business Research Company

Solid Tumor Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

Bone Cancer Treatment Market Report

https://www.thebusinessresearchcompany.com/report/bone-cancer-treatment-global-market-report

Intratumoral Cancer Therapies Market Report

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795